Ahmed Ala Eldin H, Yacoub Tariq E
Department of Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Clin Med Insights Circ Respir Pulm Med. 2010 Jun 17;4:1-8. doi: 10.4137/ccrpm.s5066.
Epmyema thoracis is associated with high mortality ranging between 6% to 24%. The incidence of empyema is increasing in both children and adults; the cause of this surge is unknown. Most cases of empyema complicate community- or hospital-acquired pneumonia but a proportion results from iatrogenic causes or develops without pneumonia. Parapneumonic effusions (PPE) develop in about one half of the patients hospitalized with pneumonia and their presence cause a four-fold increase in mortality. Three stages in the natural course of empyema have long been described: the exudative, fibrinopurulent, and organizing phases. Clinically, PPE are classified as simple PPE, complicated PPE, and frank empyema. Simple PPE are transudates with a pH > 7.20 whereas complicated PPE are exudates with glucose level <2.2 mmol/l and pH < 7.20. Two guidelines statements on the management of PPE in adults have been published by the American College of Chest Physicians (ACCP) and the British Thoracic Society (BTS). Although they differ in their approach on how to manage PPE, they agree on drainage of the pleural space in complicated PPE and frank empyema. They also recommend the use of intrapleural fibrinolysis and surgical intervention in those who do not show improvement, but the level of evidence for the use of intrapleural fibrinolysis is not high highlighting the need for more research in this area. A recently published large randomized trial has shown no survival advantage with the use of intrapleural streptokinase in patients with pleural infection. However, streptokinase enhances drainage of infected pleural fluid and may still be used in patients with large collection of infected pleural fluid causing breathlessness or ventilatory failure. There is emerging evidence that the combination of intrapleural tPA/DNase is significantly superior to tPA or DNase alone, or placebo in improving pleural fluid drainage in patients with pleural space infection. A guideline statement on the management of PPE in children has been published by the BTS. It recommends the use of antibiotics in all patients with PPE in addition to either video-assisted thoracoscopic surgery (VATS) or tube thoracostomy and intrapleural fibrinolysis. Prospective randomized trials have shown that intrapleural fibrinolysis is as effective as VATS for the treatment of childhood empyema and is a more economic treatment and therefore, should be the primary treatment of choice.
脓胸的死亡率较高,在6%至24%之间。儿童和成人脓胸的发病率均在上升,其上升原因尚不清楚。大多数脓胸病例是社区获得性或医院获得性肺炎的并发症,但一部分是医源性原因导致的,或者在没有肺炎的情况下发生。约一半因肺炎住院的患者会出现类肺炎性胸腔积液(PPE),其存在会使死亡率增加四倍。脓胸自然病程长期以来被描述为三个阶段:渗出期、纤维脓性期和机化期。临床上,PPE分为单纯性PPE、复杂性PPE和真性脓胸。单纯性PPE为pH>7.20的漏出液,而复杂性PPE为葡萄糖水平<2.2 mmol/l且pH<7.20的渗出液。美国胸科医师学会(ACCP)和英国胸科学会(BTS)已发表了两份关于成人PPE管理的指南声明。尽管它们在PPE管理方法上存在差异,但在复杂性PPE和真性脓胸的胸腔引流方面达成了一致。它们还建议对无改善的患者使用胸膜内纤维蛋白溶解和手术干预,但胸膜内纤维蛋白溶解使用的证据水平不高,这凸显了该领域需要更多研究。最近发表的一项大型随机试验表明,胸膜内使用链激酶对胸膜感染患者并无生存优势。然而,链激酶可促进感染性胸腔积液的引流,对于因大量感染性胸腔积液导致呼吸困难或呼吸衰竭的患者仍可使用。有新证据表明,胸膜内使用组织型纤溶酶原激活剂(tPA)/脱氧核糖核酸酶(DNase)联合用药在改善胸膜腔感染患者的胸腔积液引流方面明显优于单独使用tPA或DNase,或使用安慰剂。BTS已发表了一份关于儿童PPE管理的指南声明。它建议所有PPE患儿除了接受电视辅助胸腔镜手术(VATS)或胸腔闭式引流术及胸膜内纤维蛋白溶解治疗外,还应使用抗生素。前瞻性随机试验表明,胸膜内纤维蛋白溶解治疗儿童脓胸的效果与VATS相同,且是一种更经济的治疗方法,因此应作为首选的主要治疗方法。